Skip to main content

Table 1 Effect of GME at various doses on the serum lipid profiles in STZ-treated diabetic rats

From: Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats

Experimental group

TG (mg/dL)

TC (mg/dL)

HDL (mg/dL)

LDL (mg/dL)

VLDL (mg/dL)

Normal control

85.00 ± 3.20

73.83 ± 4.35

15.50 ± 0.57

41.34 ± 4.45

17.00 ± 0.64

Diabetic control

219.5 ± 7.66*

133.5 ± 3.15*

11.46 ± 1.31

78.14 ± 4.61*

43.9 ± 1.53*

STZ + 0.5 mg/kg glibenclamide

104.17 ± 3.48**

71 ± 3.53**

20.26 ± 1.23**

29.91 ± 4.00**

20.83 ± 0.70**

STZ + 50 mg/kg GME

159.67 ± 5.23**

92 ± 2.32**

13.42 ± 1.28

46.65 ± 3.47**

31.93 ± 1.05**

STZ + 100 mg/kg GME

131.67 ± 5.37**

91.5 ± 2.17**

12.92 ± 1.02

52.25 ± 2.20**

26.33 ± 1.07**

STZ + 200 mg/kg GME

133.17 ± 3.40**

73.67 ± 4.06**

15.5 ± 1.20

31.53 ± 4.34**

26.63 ± 0.68**

  1. *significantly different (p < 0.05) when compared to the normal control group of the respective column
  2. ** significantly different (p < 0.05) when compared to the diabetic control group of the respective column
  3. Data are expressed as mean ± S.E.M. for six separate observations (n = 6); One-way ANOVA test followed by Tukey’s post-hoc test (p < 0.05) was used to analyse differences among the selected lipid profiles